How Wellthy Therapeutics
enabled evidence based remote care for a Leading health insurance provider?
Chronic Diseases are projected to account for 53% of all deaths in India. Deaths from chronic disease patients are poised to grow at 18% and specific to diabetes will increase by 35%. The rise of chronic diseases imposes a huge health risk and economic burden over the healthcare industry. With the onset of Covid-19, the Health insurance firm wanted to provide additional care – personalized, remote care to its chronic disease insured or diagnosed patients with the goal to improve health and economic outcomes for its insurers
Register Now to download the complete Case Study!